Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer?

Authors :: William Balzi
Sara Bravaccini
Mattia Altini
Michela Palleschi
Ilaria Massa
Sara Ravaioli
Maria Maddalena Tumedei
Andrea Rocca
Roberta Maltoni
Maltoni, Roberta
Palleschi, Michela
Altini, Mattia
Massa, Ilaria
Balzi, William
Ravaioli, Sara
Tumedei, Maria Maddalena
Rocca, Andrea
Bravaccini, Sara
Publication Year :: 2020
Abstract: N/A

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Early breast cancer
adjuvant therapy
body mass index
medicine.disease
HER2-positive
estrogen receptor
trastuzumab
Breast cancer
Hormone receptor
Internal medicine
medicine
Stage (cooking)
business

Tools